CDKN2A and pancreatic neoplasm: It has been found to be frequently co-deleted with the neighboring tumor suppressor gene CDKN2A (which codes p16-INK4a and p14ARF) in various tumors, and its deletion has been reported in a significantly high proportion in pancreatic cancer [76,104].